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ObituaryTony Pawson: In MemoriamWe lost a star scientist this summer, Tony
Pawson, who made incredible contribu-
tions in his shortened career to our under-
standing of the biochemical mechanisms
of cell signaling. Tony, a Canadian of
British origin, performed groundbreaking
research spanning nearly 40 years that
provided tremendous insight into how
biochemical signals communicate infor-
mation both between and inside cells.
He was the first to recognize that the
transduction of these biochemical signals
often involve strong noncovalent protein-
protein interactions formed by highly
conserved noncatalytic domain segments
of signaling molecules, the prototype be-
ing the Src homology 2 ‘‘SH2’’ domain
that he and graduate student Ivan Sado-
wski first coined back in the 1980s during
early work on the oncogenic v-fps protein
encoded by the Fujinami sarcoma virus
(Sadowski et al., 1986). Tony subse-
quently demonstrated that these SH2 do-
mains bound with high affinity to select
phosphotyrosine-containing motifs in
their target proteins, the first report being
a landmark paper published in 1990 (An-
derson et al., 1990). These crucial findings
were rapidly confirmed and expanded
upon by Tony’s group and many other
laboratories in the 1990s. The biological
significance of the SH2 domain in neuro-
biology was first uncovered by Tony utiliz-
ing the power of Drosophila genetics.
Here, graduate student Paul OlivierTony Pawson enjoying a family vacation in Greve, Tuscany. Photo
contributed by his daughter, Catherine Pawson.investigated how the small
protein Drk (aka Grb2), con-
sisting of only SH2 and SH3
domains and no inherent
catalytic activity, could
have such a profound effect
on R7 photoreceptor cell
development—and made
the intriguing discovery
that the sole function of
this protein was to act as
an ‘‘adaptor’’ molecule that
connected the Sevenless
receptor tyrosine kinase to
Ras signaling inside of the
cell (Olivier et al., 1993).
Because of Tony’s ground-
breaking research on the
SH2 domain, we all now un-1042 Neuron 79, September 18, 2013 ª2013derstand that essential chemical signals
initiated by catalytic proteins, such as
tyrosine kinases and Ras-type GTPases,
involves a complex array of protein-pro-
tein interactions mediated by distinct pro-
tein module ‘‘adaptor’’ domains that func-
tion to regulate signaling networks
(Pawson, 1995). We now all take for
granted the diverse group of protein-pro-
tein interaction modules like the SH2,
SH3, PTB, 14-3-3, PDZ, WW, SAM, LIM,
PH, and BAR domains that provide a cen-
tral framework for how biochemical infor-
mation is propagated. We must
remember that Tony was the pioneer.
Though originally focused on cancer
research, the ramifications of Tony’s
work spans all fields of biology and life
sciences. You name it and his research
findings impacted it, from embryology to
immunology, cancer biology, and of
course, neuroscience. Intrigued by axon
guidance and the multitude of signals
that must occur during this complicated
biological process, Tony’s laboratory
probed the question with a series of
biochemical, cellular, and genetic tests
in mice focusing on the Eph family of
receptor tyrosine kinases and their
membrane-bound Ephrin ligands. Their
findings changed the way we think
about developmental neurobiology. They
showed that Ephs, when stimulated by
Ephrins, not only lead to signal transduc-
tion in the ‘‘receptor’’-expressing cell butElsevier Inc.also activate signaling into the ‘‘ligand’’-
expressing cells—and this bidirectional
signaling or cellular crosstalk is critical
during the intricate process of guiding
axons to their correct destinations (Hen-
kemeyer et al., 1996). The idea that bidi-
rectional cell-cell—or more precisely
axon-cell—contact-mediated Eph-Ephrin
interactions help instruct the wiring of
the brain set the stage for our understand-
ing how this large family of interacting re-
ceptors and ligands controls all sorts of
cellular migration/adhesion-type events,
including neuronal migration, synapse
formation, and synaptic plasticity in the
brain; the regulation of blood vessel
growth throughout the body; midline
development of the embryo; and of
course stem cell biology.
Based on work from Tony’s laboratory
and others, new classes of drug discovery
were enabled that ultimately led to the
development of cell signaling modulators
that treat disease—such as Gleevac,
Nexavar, and Zelboraf. And while the SH2
domain and its biological function was his
central discovery, he often ventured far
away from his comfort zone and was able
to tackle questions using myriad tools
and model organisms he could get his
hands on—from yeast to C. elegans,
Drosophila, and Mus musculus—anything
he could use to fulfill his desire to under-
stand how cells communicate. His thirst
for knowledge was never quenched, andwe who had the chance to
work in his laboratory got to
see firsthand how excited and
passionate his never-ending
love of discovery was. Those
whoheardhimon the lecturecir-
cuit and had the chance to
interact with him during his
travels got just a taste of his bril-
liance. He truly was an amazing
person, with a gentle yet
forceful ability to stimulate
theminds of themany scientists
he had trained and inspired. To
quote three enduring words we
and others surely remember
coming from Tony’s wonderful
English accent when discussing
an exciting new result or
Neuron
Obituarydesigning a cutting-edge experiment to
answer an intriguing question, ‘‘I love it.’’
Rest in peace Tony.
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